Crea sito

Multiple Sclerosis Updates

Multiple Sclerosis News

Relapsing-remitting multiple sclerosis: Plegridy, a PegInterferon beta-1a, approved in European Union

The European Commission ( EC ) has granted marketing authorization for Plegridy ( Peginterferon beta-1a ) as a treatment for adults with relapsing-remitting multiple sclerosis ( RRMS ), the most common form of multiple sclerosis. Plegridy is dosed … more

Multiple sclerosis: Gilenya reduced relapse rates, new MRI lesion counts, brain volume loss and disability progression in previously-treated patients with high disease activity

New analyses of pooled data from the FREEDOMS and FREEDOMS II trials have shown the consistent efficacy of Gilenya ( Fingolimod ) on four key measures of multiple sclerosis disease activity – reducing relapses, new MRI lesion counts, brain volume … more

Atacicept increases clinical disease activity in relapsing multiple sclerosis

Depletion of B lymphocytes is associated with suppression of inflammatory activity in multiple sclerosis. A study has assessed the safety and efficacy of Atacicept, a recombinant fusion protein that suppresses B-cell function and antibody … more

Current perspectives on chronic cerebrospinal venous insufficiency

Chronic cerebrospinal venous insufficiency ( CCSVI ) was initially defined as a clinical syndrome comprising stenoses of the internal jugular and/or azygos veins, characterized by collateral venous outflows and reduced cerebral blood flow, and was … more